Similarly, upregulation of SLC2A6 (A.K.A. GLUT6) was reported to promote glucose uptake 39, while POLR2K upregulation was found to increase nucleic acid metabolism 40 in aggressive cancers. The gene discussed is SLC2A6; the disease is cancer.